CuraVac is ready for a phase 2 demonstration of efficacy with an even more potent formulation of the Therapeutic Vaccine CV-MG02. We already have half the financing, and we are now looking for the other half. If you want to help us and be part of this demonstration of efficacy, please contact us.
